Pfizer (PFE) Recalls Citalopram, Finasteride on Mislabeling

Pfizer Inc (NYSE:PFE) via its Greenstone LLC unit announced it is recalling two drugs in the United States because they may have been incorrectly labeled by another manufacturer they hired for that purpose.

According to the company, the two drugs being recalled are Citalopram and Finasteride, with some bottles of Citalopram, a depression drug, possibly being labeled inaccurately as Finasteride, which is used to treat benign prostatic hyperplasia, and vice versa,

Women who are pregnant should not handle or ingest Finasteride due to risks of side effects that can cause fetal abnormalities, warned Greenstone.

The recall is voluntary, and at this time there have been no illnesses or injuries connected to the situation.

Pfizer closed Friday at $20.35, gaining $0.05, or 0.25 percent.